Lilly Diabetes

Lilly has been a global leader in diabetes care since 1923 and introduced world’s first commercial insulin

Lilly has been a global leader in diabetes care since 1923, when we introduced the world’s first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research and collaboration, a broad and growing product portfolio and a continued determination to provide real solutions—from medicines to support programs and more—we strive to make life better for all those affected by diabetes around the world.

What Makes Lilly Unique

A major emphasis of our work is to understand that people with diabetes should first be seen as individuals. Many of our programs and solutions are designed based on feedback from people who live with the illness every day. We also understand that diabetes is bigger than any one company. Fighting the growing diabetes epidemic goes beyond the capabilities of any one entity or therapy. For some countries, Lilly Diabetes’ donation of insulin vials to the Life for a Child program and our educational grant in support of the International Diabetes Federation's Bridges program—which supports translational research in local communities—represent just a few examples of our long-term commitment to diabetes care.

For more information, visit

For any further specific healthcare related inquiries, please consult your healthcare professional.